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Despite recent progress in diagnosis, medical treatment and 
clinical approach in heart failure (HF) still the prevalence of this 
clinical syndrome remains high mainly due to aging of popula-
tion.1,2,3,4 Estimates illustrate a 46% increase in HF prevalence 
by 2030.5  
Depression is five times more prevalent in HF patients when 
compared to general population.1  Prevalence of major depres-
sion in chronic HF is about 20–40%, which is 4–5% higher than 
general population.3 Additionally, depression is present in one 
in five HF patients with 48% of them  suffering from severe 
depression.3 According to estimates, prevalence of depression 
ranges  from 9 to 60% with higher prevalence among women 
(32.7%) than men (26.1%).3,6 Differences are also observed 
among age groups with younger HF patients to experience  
more depressive symptoms than older.6 Notably, these dissimi-
larities are mainly attributed to the methodology used in re-
search studies across the world.  
Impressively, depression is associated with increased mortali-
ty3 and more in detail, depressive symptoms or a depressive 
disorder is associated with a 2-fold increased risk of death or 
cardiac events.5,6 Impressively, 50% of HF patients die within 
five years after diagnosis.5 Depression is also an independent 
risk factor for mortality in HF, regardless of New York 
Heart Association functional class (NYHA).4  
Moreover, depression is as a predictor of adverse clinical out-
comes7 and increased healthcare use including a 2-fold risk of 
emergency room visits and high hospital readmission rates.5 A 
possible explanation for the association between depression 
and poor HF clinical outcomes is that this mental disorder con-
sists an important barrier to HF self-care. Indeed, self-
management plays an important role in the likelihood of 
adopting and maintaining health behaviour changes and 
therefore is associated with improved HF clinical and social 
outcomes.8,9 
Several demographic and clinical characteristics are associated 
with depression in relevant research studies. A recent study 
conducted by Zahid et al.,2 among 170 HF patients demon-
strated that 102 (60%) had depression, of whom 42% (n=43) 
had mild depression. Predictors of depression were New York 
Heart Association 3rd or 4th stage, prior myocardial infarction, 
living without a partner, lack of family cohesion, sedentary life-
style, aged 70 years or more, and hospitalization at least once 
in the past two months. 
In Greece, a study among 190 hospitalized HF patients in four 
public hospitals, showed that 17.4% had minor and 24.2% ma-
jor depression as measured by the Hospital Anxiety 
and Depression Scale (HADS).10 A prior study illustrated severe 
depression in 17.2% of 139 HF patients (79.1% male) 
with participants at 2nd or 3rd stage of NYHA classification to 
experience higher levels of depression.11 
A study among 150 HF Greek patients showed that patients 
with symptoms of depression had impaired physical activity 
associated with excessive hormonal activation. Depression as 
measured by the Zung-Depression scale appeared to be an 
independent predictor of the clinical outcome, especially in 
patients with elevated levels of plasma B-type natriuretic pep-
tide (BNP levels). 12 
HF as a chronic and debilitating clinical syndrome involves var-
ious and daily limitations in patients' life  mainly attributed to 
cognitive and physical impairments that accompany the dis-
ease. Moreover, HF implies a heavy personal,  family, social and 
economic burden for each individual.13 Interestingly, consider-
able frustration and discouragement may arise from the inabil-
ity to perform normal activities of daily living, such as washing, 
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dressing, going upstairs or driving the car.14  Strikingly more, in 
Greece, the long waiting list for organ donation may trigger 
depression through the fear of death before finding a donor. 11 
Assessing depression within the context of this clinical syn-
drome is considered as a great challenge because these two 
diseases (HF and depression) share common physical and 
emotional symptoms. Also, depression in HF, is an independent 
predictor of future cardiac events, regardless of disease severi-
ty, making it worthwhile to be seriously considered among 
other cardiac risk factors.15 
Depressive symptomatology as well as its' exacerbating effect 
on the prognosis of HF, illustrates the emergency for prompt 
diagnosis and treatment which may avert further pathophysio-
logical consequences for the heart and brain.16  
Last but not least, strengthening self management among HF 
patients and maximizing behavioral interventions, may alleviate 
this emotional burden, thus improving their quality of life. 17 
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